EIF2AK2 and Wilson disease: Herein, we used a TX mouse model of WD to verify whether the PKR inhibitor C16 can regulate the PKR/eIF2α pathway, prevent copper-induced synaptic dysfunction, and serve as a neuroprotective agent to improve cognitive function in WD mice with cognitive impairment.